There were two genes, in addition to HER2, clearly overexpressed in HER2+ tumours, GRB7 and MED24, which are both upstream of ERBB2 on chromosome 17 and previously associated with the HER2+ subtype (Sørlie, 2004). Here, MED24 is linked to neoplasm.